Cocaine Abuse and Attention Deficit Disorder - 3
Not Applicable
Completed
- Conditions
- Cocaine-Related Disorders
- Registration Number
- NCT00000268
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
- Detailed Description
To evaluate the safety and efficacy of methylphenidate and bupropion in treating individuals with adult Attention Deficit Disorder.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
current adult ADHD current cocaine dependence
Exclusion Criteria
no current major depression
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Side effects Drug use ADHD symptoms Improvement in functioning Craving Tolerability
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie methylphenidate's efficacy in treating adult ADHD with cocaine abuse?
How does bupropion compare to other dopamine reuptake inhibitors in managing cocaine use disorder?
Are there specific biomarkers that predict response to methylphenidate or bupropion in cocaine-related disorders?
What are the potential adverse events associated with methylphenidate and bupropion in adult ADHD patients with substance use disorders?
What combination therapies or alternative drugs are being explored for treating comorbid attention deficit disorder and cocaine abuse?
Trial Locations
- Locations (1)
New York State Psychiatric Institute
🇺🇸New York, New York, United States
New York State Psychiatric Institute🇺🇸New York, New York, United States